Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids
Abstract Here we sought to determine the relationship between STAT3 activity and Galectin‐3 (Gal‐3) and to investigate the cytotoxic effect of PectaSol‐C Modified Citrus Pectin (Pect‐MCP) as a specific competitive inhibitor of Galectin‐3 (Gal‐3) in combination with Paclitaxel (PTX) to kill the ovari...
Main Authors: | Ghamartaj Hossein, Sina Halvaei, Yassaman Heidarian, Zeinab Dehghani‐Ghobadi, Mina Hassani, Homa Hosseini, Nima Naderi, Shahrzad Sheikh Hassani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2334 |
Similar Items
-
The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?
by: Lucas de Freitas Pedrosa, et al.
Published: (2022-02-01) -
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01) -
Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01) -
The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01) -
Placental galectin-3 is reduced in early-onset preeclampsia
by: Manju Kandel, et al.
Published: (2022-10-01)